Warning letter
GAR Laboratories: warning letter of Nov 20, 2001
FDA warning letter UCM178552 · Los Angeles District Office
Key facts
| Reference number | UCM178552 |
|---|---|
| Company | GAR Laboratories |
| Subject | Current Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated |
| Issue date | Nov 20, 2001 |
| Posted date | Nov 20, 2001 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 211, 211.67, 211.80, 211.100, 211.160, 211.186, 211.100(b), 211.165(a) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: